Evidence map›Paper›PMID 41971158›Full record

ArticleBio-protocol2026

3D STED Super-Resolution Imaging Strategy for Visualizing Synaptic Nano-architecture in Brain Cryosections.

James Scripter, Adam Skeens, Grace Jones, Yeasmin Akter, Martin Hruska

Abstract read
In one paragraph

Article in Bio-protocol, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

James ScripterDepartment of Neuroscience, Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV, USA.
Adam SkeensDepartment of Neuroscience, Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV, USA.
Grace JonesDepartment of Neuroscience, Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV, USA.
Yeasmin AkterDepartment of Neuroscience, Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV, USA.
Martin HruskaDepartment of Neuroscience, Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV, USA.

Funding

Nanoscale synaptic heterogeneity, loss, and plasticity in Alzheimer's diseaseR01AG091548 · NIA · WEST VIRGINIA UNIVERSITY · PI Martin Hruska · 2026 to 2026
$476k
NIA NIH HHS R01 AG091548
6 · The paper itself

Abstract

Super-resolution imaging of synapses in intact brain tissue remains challenging because light scattering, photobleaching, and limited probe penetration, along with antigen accessibility within the densely packed postsynaptic densities (PSDs), constrain resolution and labeling efficiency. Here, we present a protocol utilizing thin brain cryosections and tau-stimulated emission depletion (STED) nanoscopy to visualize the intricate nano-architecture of excitatory synapses in situ. Slicing the brain into 6 μm sections allows for highly efficient and even penetration of probes throughout sections while ensuring that the resolution is not significantly impacted by the imaging depth of the tissue. We outline step-by-step instructions for labeling pre- and postsynaptic nano-architecture using antibodies and nanobodies, highlighting how fixative choice influences the labeling efficiency of synaptic proteins. While this protocol is compatible with both confocal and super-resolution imaging, when combined with rapid image acquisition times of tau-STED, it enables clear separation of key synaptic features in three dimensions with minimal photobleaching. Thus, this approach enables robust multiplex imaging of fluorescently labeled synaptic proteins in the brain, providing exceptional spatial resolution for visualization and quantification of synaptic nanoarchitecture in its native environment. Key features • Detailed protocol for in situ 3D STED microscopy with ~50 nm XY and ~100 nm Z resolution. • Optimized strategies for labeling pre- and postsynaptic nano-architecture using antibodies and nanobodies, including guidance on fixative choice. • Unified workflow for visualizing synaptic morphology and nanoarchitecture to uncover molecular synaptic diversity in the brain at the nanoscale.

Indexed as

Brain cryosectionsExcitatory synapseGlyoxalNanobodyParaformaldehydePSD-95Tau-STED microscopy

Identifiers

PMID41971158
PMCPMC13067153

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.